Pharming Group N.V. (AMS:PHARM)

Pharming Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	838	977	627	690	707	503
Market Cap Growth	43.32%	55.71%	-9.08%	-2.41%	40.66%	-38.05%
Enterprise Value	791	947	587	658	657	487
Last Close Price	1.19	1.43	0.93	1.03	1.08	0.78
PE Ratio	83.82	402.37	-	-	55.27	35.75
Forward PE	42.93	-	-	153.88	27.10	14.49
PS Ratio	2.61	3.05	2.19	3.11	3.68	2.88
PB Ratio	3.59	4.14	2.94	3.49	3.69	2.96
P/TBV Ratio	7.00	8.10	4.06	5.17	5.82	5.23
P/FCF Ratio	17.33	21.26	-	-	35.85	21.10
P/OCF Ratio	17.12	20.97	-	-	33.66	15.11
EV/Sales Ratio	2.47	2.96	2.05	2.97	3.41	2.78
EV/EBITDA Ratio	19.72	28.07	188.69	-	40.97	18.22
EV/EBIT Ratio	25.77	33.94	-	-	67.70	23.07
EV/FCF Ratio	16.36	20.61	-	-	33.29	20.43
Debt / Equity Ratio	0.43	0.42	0.51	0.78	0.82	0.84
Debt / EBITDA Ratio	2.54	2.69	17.02	-	8.46	4.88
Debt / FCF Ratio	2.09	2.15	-	-	7.91	5.97
Net Debt / Equity Ratio	-0.20	-0.23	-0.25	-0.19	-0.20	-0.16
Net Debt / EBITDA Ratio	-1.28	-1.60	-17.24	2.74	-2.37	-0.99
Net Debt / FCF Ratio	-0.97	-1.17	21.50	2.24	-1.93	-1.11
Asset Turnover	0.83	0.84	0.69	0.55	0.50	0.49
Inventory Turnover	0.71	0.75	0.63	0.51	0.50	0.87
Quick Ratio	2.05	1.97	2.96	3.28	3.90	4.69
Current Ratio	2.63	2.59	3.77	4.06	4.65	5.33
Return on Equity (ROE)	5.04%	1.02%	-5.38%	-4.98%	6.88%	8.50%
Return on Assets (ROA)	4.89%	4.55%	-0.52%	-3.06%	1.57%	3.68%
Return on Invested Capital (ROIC)	10.00%	3.41%	-2.10%	-12.76%	5.79%	10.98%
Return on Capital Employed (ROCE)	9.30%	8.50%	-1.10%	-5.70%	2.80%	6.80%
Earnings Yield	1.28%	0.25%	-1.82%	-1.38%	1.81%	2.80%
FCF Yield	5.77%	4.70%	-0.40%	-2.46%	2.79%	4.74%
Buyback Yield / Dilution	-13.48%	-11.25%	-2.18%	7.09%	-0.85%	-2.70%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.